Composite Outcomes Can Distort the Nature and Magnitude of Treatment Benefits in Clinical Trials

被引:12
作者
Ferreira-Gonzalez, Ignacio [1 ]
Permanyer-Miralda, Gaieta [1 ]
Busse, Jason W. [2 ]
Devereaux, P. J. [2 ]
Guyatt, Gordon H. [2 ]
Alonso-Coello, Pablo [3 ]
Montori, Victor M. [4 ]
机构
[1] Hosp Gen Valle Hebron, CIBER Epidemiol & Salud Publ, Barcelona 08035, Spain
[2] McMaster Univ, Hamilton, ON L8N 3Z5, Canada
[3] Hosp Santa Creu & Sant Pau, Iberoamer Cochrane Ctr, CIBER Epidemiol & Salud Publ, Barcelona 08025, Spain
[4] Mayo Clin, Rochester, MN 55905 USA
关键词
END-POINTS; RANDOMIZED-TRIALS;
D O I
10.7326/0003-4819-150-8-200904210-00016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:566 / 567
页数:2
相关论文
共 6 条
  • [1] Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials
    Ferreira-Gonzalez, I.
    Busse, J. W.
    Heels-Ansdell, D.
    Montori, V. M.
    Akl, E. A.
    Bryant, D. M.
    Alonso, J.
    Jaeschke, R.
    Schuenemann, H. J.
    Permanyer-Miralda, G.
    Domingo-Salvany, A.
    Guyatt, G. H.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7597): : 786 - 788A
  • [2] Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns
    Ferreira-Gonzalez, Ignacio
    Permanyer-Miralda, Gaieta
    Busse, Jason W.
    Bryant, Dianne M.
    Montori, Victor M.
    Alonso-Coello, Pablo
    Walter, Stephen D.
    Guyatt, Gordon H.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2007, 60 (07) : 651 - 657
  • [3] Composite outcomes in randomized trials - Greater precision but with greater uncertainty?
    Freemantle, N
    Calvert, M
    Wood, J
    Eastaugh, J
    Griffin, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (19): : 2554 - 2559
  • [4] Guyatt G, 2008, USERS GUIDES MED LIT, P237
  • [5] Composite Outcomes in Cardiovascular Research: A Survey of Randomized Trials
    Lim, Eric
    Brown, Adam
    Helmy, Adel
    Mussa, Shafi
    Altman, Douglas G.
    [J]. ANNALS OF INTERNAL MEDICINE, 2008, 149 (09) : 612 - +
  • [6] Validity of composite end points in clinical trials
    Montori, VM
    Permanyer-Miralda, G
    Ferreira-González, I
    Busse, JW
    Pacheco-Huergo, V
    Bryant, D
    Alonso, J
    Akl, EA
    Domingo-Salvany, A
    Mills, E
    Wu, P
    Schünemann, HJ
    Jaeschke, R
    Guyatt, GH
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7491): : 594 - 596